| dc.contributor.author | Semirgin S.U. | |
| dc.contributor.author | Basoglu T. | |
| dc.contributor.author | Sahin M. | |
| dc.contributor.author | Yapici O. | |
| dc.date.accessioned | 2020-06-21T09:04:44Z | |
| dc.date.available | 2020-06-21T09:04:44Z | |
| dc.date.issued | 2017 | |
| dc.identifier.issn | 1309-4483 | |
| dc.identifier.uri | https://doi.org/10.5835/jecm.omu.34.02.010 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/2099 | |
| dc.description.abstract | Synchronous cancer refers to a new primary cancer in a person with a history of malignant disease. It may be easily missed in early stages of its development. Besides its high sensitivity in the diagnosis of malignant disease, FDG-PET/ CT has a technical advantage due to routinely performed whole-body scanning procedures in the detection of synchronous cancers. In this case report, we discussed two cases in which synchronous cancer was incidentally detected by FDG-PET/CT whole body examination. © 2017 OMU. | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Ondokuz Mayis Universitesi | en_US |
| dc.relation.isversionof | 10.5835/jecm.omu.34.02.010 | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | F18-FDG | en_US |
| dc.subject | PET/CT | en_US |
| dc.subject | Second primary tumor | en_US |
| dc.subject | Synchronous cancer | en_US |
| dc.title | Diagnostic value of FDG-PET/CT in the detection of synchronous cancers | en_US |
| dc.type | article | en_US |
| dc.contributor.department | OMÜ | en_US |
| dc.identifier.volume | 34 | en_US |
| dc.identifier.issue | 2 | en_US |
| dc.identifier.startpage | 137 | en_US |
| dc.identifier.endpage | 140 | en_US |
| dc.relation.journal | Journal of Experimental and Clinical Medicine (Turkey) | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
